BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2971046)

  • 1. Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site.
    Yoshida N; Terukina S; Okuma M; Moroi M; Aoki N; Matsuda M
    J Biol Chem; 1988 Sep; 263(27):13848-56. PubMed ID: 2971046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerization defect of fibrinogen Baltimore III due to a gamma Asn308----Ile mutation.
    Bantia S; Bell WR; Dang CV
    Blood; 1990 Apr; 75(8):1659-63. PubMed ID: 2328317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A re-examination of the cleavage of fibrinogen and fibrin by plasmin.
    Ferguson EW; Fretto LJ; McKee PA
    J Biol Chem; 1975 Sep; 250(18):7210-8. PubMed ID: 126232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
    Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S
    Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal plasmic cleavage of the gamma-chain variant of "fibrinogen Saga" with an Arg-275 to His substitution.
    Yamazumi K; Terukina S; Onohara S; Matsuda M
    Thromb Haemost; 1988 Dec; 60(3):476-80. PubMed ID: 2976995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogen.
    Southan C; Thompson E; Panico M; Etienne T; Morris HR; Lane DA
    J Biol Chem; 1985 Oct; 260(24):13095-101. PubMed ID: 2932434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of segments essential for polymerization and for calcium binding in the gamma-chain of human fibrinogen.
    Váradi A; Scheraga HA
    Biochemistry; 1986 Feb; 25(3):519-28. PubMed ID: 2937452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of gamma Arg-275 by Cys in an abnormal fibrinogen, "fibrinogen Osaka II". Evidence for a unique solitary cystine structure at the mutation site.
    Terukina S; Matsuda M; Hirata H; Takeda Y; Miyata T; Takao T; Shimonishi Y
    J Biol Chem; 1988 Sep; 263(27):13579-87. PubMed ID: 2971042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an abnormal fibrinogen Osaka V with the replacement of gamma-arginine 375 by glycine. The lack of high affinity calcium binding to D-domains and the lack of protective effect of calcium on fibrinolysis.
    Yoshida N; Hirata H; Morigami Y; Imaoka S; Matsuda M; Yamazumi K; Asakura S
    J Biol Chem; 1992 Feb; 267(4):2753-9. PubMed ID: 1733971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An apparently higher molecular weight gamma-chain variant in a new congenital abnormal fibrinogen Tochigi characterized by the replacement of gamma arginine-275 by cysteine.
    Yoshida N; Ota K; Moroi M; Matsuda M
    Blood; 1988 Feb; 71(2):480-7. PubMed ID: 3337908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.
    Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ
    Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen Kyoto III: a congenital dysfibrinogen with a gamma aspartic acid-330 to tyrosine substitution manifesting impaired fibrin monomer polymerization.
    Terukina S; Yamazumi K; Okamoto K; Yamashita H; Ito Y; Matsuda M
    Blood; 1989 Dec; 74(8):2681-7. PubMed ID: 2819242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization.
    Steinmann C; Reber P; Jungo M; Lämmle B; Heinemann G; Wermuth B; Furlan M
    Blood; 1993 Oct; 82(7):2104-8. PubMed ID: 8400260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp----Val impairs fibrin polymerization.
    Reber P; Furlan M; Rupp C; Kehl M; Henschen A; Mannucci PM; Beck EA
    Blood; 1986 Jun; 67(6):1751-6. PubMed ID: 3708159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Haifa: fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains.
    Soria J; Soria C; Samama M; Tabori S; Kehl M; Henschen A; Nieuwenhuizen W; Rimon A; Tatarski I
    Thromb Haemost; 1987 Jun; 57(3):310-3. PubMed ID: 2958955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in electrophoretic mobility and plasmic digestion profile between four recombinant fibrinogens, gamma 308K, gamma 308I, gamma 308A, and wild type (gamma 308N).
    Okumura N; Terasawa F; Fujita K; Tozuka M; Ota H; Katsuyama T
    Electrophoresis; 2000 Jul; 21(12):2309-15. PubMed ID: 10939439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of a fibrinogen calcium binding site between gamma-subunit positions 311 and 336 by terbium fluorescence.
    Dang CV; Ebert RF; Bell WR
    J Biol Chem; 1985 Aug; 260(17):9713-9. PubMed ID: 3160702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Milano XII: a dysfunctional variant containing 2 amino acid substitutions, Aalpha R16C and gamma G165R.
    Bolliger-Stucki B; Lord ST; Furlan M
    Blood; 2001 Jul; 98(2):351-7. PubMed ID: 11435303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization.
    Koopman J; Haverkate F; Briët E; Lord ST
    J Biol Chem; 1991 Jul; 266(20):13456-61. PubMed ID: 2071611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.